Kozak & Associates’s Amgen AMGN Stock Holding History

Kozak & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$140K	Buy	389 +6	+2%	+$2.05K	0.02%	85
2026 Q1	$134K	Buy	383 +2	+0.5%	+$713	0.03%	85
2025 Q4	$124K	Buy	381 +2	+0.5%	+$634	0.02%	95
2025 Q3	$130K	Buy	379 +2	+0.5%	+$580	0.03%	102
2025 Q2	$112K	Sell	377 -19	-5%	-$5.38K	0.02%	105
2025 Q1	$116K	Buy	396 +24	+6%	+$7.09K	0.03%	95
2024 Q4	$97.1K	Buy	372 +27	+8%	+$8.01K	0.02%	102
2024 Q3	$111K	Buy	345 +87	+34%	+$28.5K	0.03%	100
2024 Q2	$79.8K	Buy	258 +2	+0.8%	+$588	0.02%	104
2024 Q1	$80.6K	Sell	256 -27	-10%	-$7.9K	0.02%	109
2023 Q4	$85.7K	Hold	283	–	–	0.03%	113
2023 Q3	$75.8K	Hold	283	–	–	0.03%	116
2023 Q2	$63.7K	Hold	283	–	–	0.03%	126
2023 Q1	$68.5K	Hold	283	–	–	0.03%	124
2022 Q4	$74K	Hold	283	–	–	0.04%	123
2022 Q3	$70K	Hold	283	–	–	0.04%	123
2022 Q2	$69K	Hold	283	–	–	0.05%	128
2022 Q1	$64K	Hold	283	–	–	0.04%	136
2021 Q4	$64K	Hold	283	–	–	0.04%	136
2021 Q3	$59K	Buy	+283	New	+$65.1K	0.03%	146

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Kozak & Associates's AMGN Position: Q2 2026 in Review

Kozak & Associates increased its Amgen (AMGN) stake by 1.6% in Q2 2026, buying an estimated $2.05K and bringing the position to 389 shares worth $140K. The position accounts for 0.02% of the portfolio, ranked #85.

Kozak & Associates first reported a position in AMGN in Q3 2021 and has held it in 20 quarters since. 1,281 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Kozak & Associates held 389 shares of Amgen worth $140K as of Q2 2026.
Kozak & Associates bought 6 Amgen shares in Q2 2026, an estimated $2.05K.
Amgen made up 0.02% of Kozak & Associates's portfolio in Q2 2026, its #85 holding.
Kozak & Associates first reported a position in Amgen in Q3 2021 and has held it in 20 quarters since.
1,281 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.